Artificial Intelligence

Born from a Novartis mega-deal, Atrium Therapeutics aims its novel RNA platform at rare, untreatable genetic heart diseases. Will its strategy succeed?

The Kansas City firm was named to the inaugural Skift M&I 15 list, a recognition fueled by key acquisitions and its pioneering AI-powered JOY Index.

The AI logistics firm's new Texas office signals a major shift, placing advanced software development at the heart of the U.S. military's operational core.

The DAF awarded Istari Digital $8.6M for Industry Øne, a platform to let defense contractors collaborate securely without sharing their sensitive data.

European biotech leader Hifas da Terra launches in the US, aiming to disrupt the mushroom supplement industry with its unique focus on clinical trials.

With 10 million users acquired organically, Presentations.AI is leading a shift from static slides to dynamic, AI-powered 'decision infrastructure'.

Following a historic $2B revenue year, Tradeweb's CEO will address institutional investors, focusing on AI, digital assets, and global market expansion.

CW Bancorp reaffirms its quarterly dividend, showcasing financial stability and its strategic focus on fueling California's small business economy.

Deal activity is surging in private markets, but a new era of selective investment and AI-driven opportunities is forcing investors to adapt. Here's the outlook.

With a fresh $10M in funding, this public safety startup aims to replace outdated police tech with an AI platform that connects the dots across jurisdictions.

With the Kroger merger off, Albertsons signals a bold new digital strategy by appointing McDonald's CIO Brian Rice to its board of directors.

A new strategic partnership puts AMC Robotics' advanced sorting robot to the test, signaling a pivotal shift from lab development to real-world logistics.

Dycom Industries will detail its role in the digital revolution at key investor conferences, backed by record earnings and a major data center acquisition.

With new funding and veteran US leadership, UK-based OSSTEC is preparing to launch its innovative ASCENT partial knee system in a competitive market.

On Rare Disease Day, Polaryx Therapeutics advances a novel oral drug in a pivotal trial for four devastating pediatric disorders, offering a new strategy.

The global Edtech firm's prestigious accreditation signals a new era of accountability, forcing a reckoning on quality in the online tutoring market.

Beyond smart automation, aim Systems will unveil a practical roadmap and new AI solutions to create fully autonomous factories at Seoul's premier tech event.

Antelope Enterprise Holdings just bought $1M in Bitcoin, launching its 'Genius Plan.' But with falling revenue, is this a bold new chapter or a risky bet?

Amid global chip uncertainty, PhotonIC debuts a multi-fab, multi-process platform designed to future-proof the optoelectronic supply chain for AI and cloud.

Following a stellar earnings report, the ad tech firm heads to key conferences to pitch its AI and privacy-first strategy in a post-cookie world.